December 14, 2024 - 14:24

The extension of the science and technology agreement between the United States and China has been finalized after months of negotiations. This decision comes in the context of increasing concerns among U.S. lawmakers regarding potential national security risks associated with ongoing cooperation with China. The renewed pact aims to facilitate collaboration in various scientific fields, including climate change, public health, and technology development.
Despite the growing rivalry between the two nations, both sides recognize the importance of scientific collaboration in addressing global challenges. The agreement allows for the exchange of researchers and information, which can foster innovation and progress. However, U.S. officials remain vigilant, emphasizing the need to safeguard sensitive technologies and intellectual property from potential exploitation.
As tensions continue to rise over trade, military presence, and human rights issues, the extension of this agreement highlights a complex relationship where cooperation and competition coexist. The impact of this renewed pact on future diplomatic relations remains to be seen.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...